Association between PSA values and surveillance quality after prostate cancer surgery

BACKGROUND: Although prostate‐specific antigen (PSA) testing is used for prostate cancer detection and posttreatment surveillance, thresholds in these settings differ. The screening cutoff of 4.0 ng/mL may be inappropriately used during postsurgery surveillance, where 0.2 ng/mL is typically used, cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chapman, Christina Hunter, Caram, Megan E. V., Radhakrishnan, Archana, Tsodikov, Alexander, Deville, Curtiland, Burns, Jennifer, Zaslavsky, Alexander, Chang, Michael, Leppert, John T., Hofer, Timothy, Sales, Anne E., Hawley, Sarah T., Hollenbeck, Brent K., Skolarus, Ted A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912050/
https://www.ncbi.nlm.nih.gov/pubmed/31691526
http://dx.doi.org/10.1002/cam4.2663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912050/
https://www.ncbi.nlm.nih.gov/pubmed/31691526
http://dx.doi.org/10.1002/cam4.2663

Ejemplares similares